Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy
Open Access
- 14 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (11) , 2397-2404
- https://doi.org/10.1111/j.1538-7836.2006.02165.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Update on Statins: 2003Circulation, 2004
- New nonlipid effects of statins and their clinical relevance in cardiovascular diseaseThrombosis and Haemostasis, 2004
- Pitavastatin-Induced Thrombomodulin Expression by Endothelial Cells Acts Via Inhibition of Small G Proteins of the Rho FamilyArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Simvastatin Lowers C-Reactive Protein Within 14 DaysCirculation, 2002
- Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertensionClinical Science, 2002
- QuinaprilDrugs, 2002
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Statins and Blockers of the Renin-Angiotensin SystemHypertension, 1999
- Angiotensin-Converting Enzyme InhibitorsCirculation, 1998